Management of Invasive Differentiated Thyroid Cancer.

Item

http://www.wikidata.org/entity/Q41912985

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Management of Invasive Differentiated Thyroid Cancer.

@en

type

Item

label

Management of Invasive Differentiated Thyroid Cancer.

@en

prefLabel

Management of Invasive Differentiated Thyroid Cancer.

@en

P1476

Management of Invasive Differentiated Thyroid Cancer

@en

P2093

Alessandra Rinaldo

http://www.w3.org/2001/XMLSchema#string

Alfio Ferlito

http://www.w3.org/2001/XMLSchema#string

Carl Silver

http://www.w3.org/2001/XMLSchema#string

Carlos Suarez

http://www.w3.org/2001/XMLSchema#string

Jatin P Shah

http://www.w3.org/2001/XMLSchema#string

Kate Newbold

http://www.w3.org/2001/XMLSchema#string

Ricard Simo

http://www.w3.org/2001/XMLSchema#string

P2860

Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: current state of the art and future directions

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Evaluation and treatment of aerodigestive tract invasion by well-differentiated thyroid carcinoma.

Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr

Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis.

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.

Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.

One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy

P304

1156-1166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/THY.2016.0064

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luiz Paulo Kowalski

Iain J. Nixon

P577

2016-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27480110

http://www.w3.org/2001/XMLSchema#string

P932

5118958

http://www.w3.org/2001/XMLSchema#string